English

MAIO, 25
SÃO PAULO – SP - BRAZIL
(NOVOTEL MORUMBI)

PERFIL DOS PARTICIPANTES

Categorias de produtos

Branded generics: 48.3%
96.6

Biological products: 43.3%
86.6

Biosimilars: 26.7%
53.4

Hospital products: 40.0%
80

Innovative medicines: 58.7%
117.4

mais informações




Interesses estratégicos

In-licensing: 46.7%
93.4

Out-licensing: 40.0%
80

Co-marketing: 31.7%
63.4

Co-promotion: 26.7%
53.4

Co-development: 46.7%
93.4

mais informações




Área terapêutica

Cardiovascular: 40.0%
80

CNS: 45.0%
90

Infectious diseases: 35.0%
70

Pain: 41.7%
83.4

Respiratory: 33.3%
66.6

mais informações



PARTICIPANTES 2016

Branded generics: 48.3%

Biological products: 43.3%

Biosimilars: 26.7%

Diagnostics: 7.5%

Distribution: 12.5%

Drug delivers technol.: 0.0%

Generics: 25.8%

Herbal medicines: 17.5%

Homeopathy: 5.0%

Hospital products: 40.0%

Innovative medicines: 58.7%

Medical devices: 19.2%

Veterinary: 8.3%

partner